Skip to main content
. 2019 Aug 24;20(9):20–30. doi: 10.1002/acm2.12697

Figure 2.

Figure 2

Results in terms of P‐values for Wilcoxon signed‐rank test obtained for target structures and dosimetric indicators (upper part) and for OARs and treated volumes (lower part). Comparisons were performed between MR‐Linac and IMRT plans obtained with traditional Linac, MR‐Linac, and VMAT plans on traditional Linac, and between the two delivery modalities of traditional Linac.